Single-cell Technology for Precision Medicine
Mission Bio develops single-cell multi-omics technology for precision medicine and cancer research. Their Tapestri platform simultaneously measures single nucleotide variation (SNV), copy number variation (CNV), and protein data from the same cells. The company serves oncology researchers and pharmaceutical developers focused on hematologic malignancies, solid tumors, cell and gene therapy, and biomarker development.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountAug 2020
Oct 2018
Oct 2017
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Global biosimulation software and services company accelerating drug development for 2,000+ bioph...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
